HIGH TIDE INC (HITI.CA) Stock Fundamental Analysis
Canada - TSX-V:HITI - CA42981E4013 - Common Stock
4.38 CAD
+0.09 (+2.1%)
We assign a fundamental rating of 4 out of 10 to HITI. HITI was compared to 31 industry peers in the Pharmaceuticals industry. The financial health of HITI is average, but there are quite some concerns on its profitability. HITI is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
HITI had negative earnings in the past year.
HITI had a positive operating cash flow in the past year.
HITI had negative earnings in each of the past 5 years.
HITI had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -3.76%, HITI is in line with its industry, outperforming 54.84% of the companies in the same industry.
The Return On Equity of HITI (-6.93%) is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 4.61%, HITI is in the better half of the industry, outperforming 77.42% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.76% | ||
| ROE | -6.93% | ||
| ROIC | 4.61% |
ROA(3y)-14.91%
ROA(5y)-13.84%
ROE(3y)-26.27%
ROE(5y)-34.31%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
HITI has a Operating Margin of 2.30%. This is in the better half of the industry: HITI outperforms 67.74% of its industry peers.
Looking at the Gross Margin, with a value of 25.83%, HITI is doing worse than 74.19% of the companies in the same industry.
HITI's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.3% | ||
| PM (TTM) | N/A | ||
| GM | 25.83% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.25%
GM growth 5Y-5.48%
2. Health
2.1 Basic Checks
HITI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, HITI has more shares outstanding
The number of shares outstanding for HITI has been increased compared to 5 years ago.
HITI has a better debt/assets ratio than last year.
2.2 Solvency
HITI has an Altman-Z score of 3.33. This indicates that HITI is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of HITI (3.33) is better than 90.32% of its industry peers.
HITI has a debt to FCF ratio of 4.08. This is a neutral value as HITI would need 4.08 years to pay back of all of its debts.
The Debt to FCF ratio of HITI (4.08) is better than 83.87% of its industry peers.
HITI has a Debt/Equity ratio of 0.43. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.43, HITI is not doing good in the industry: 61.29% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.43 | ||
| Debt/FCF | 4.08 | ||
| Altman-Z | 3.33 |
ROIC/WACC0.59
WACC7.78%
2.3 Liquidity
HITI has a Current Ratio of 1.85. This is a normal value and indicates that HITI is financially healthy and should not expect problems in meeting its short term obligations.
HITI has a Current ratio of 1.85. This is comparable to the rest of the industry: HITI outperforms 54.84% of its industry peers.
A Quick Ratio of 1.29 indicates that HITI should not have too much problems paying its short term obligations.
HITI's Quick ratio of 1.29 is in line compared to the rest of the industry. HITI outperforms 48.39% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.85 | ||
| Quick Ratio | 1.29 |
3. Growth
3.1 Past
The earnings per share for HITI have decreased strongly by -328.07% in the last year.
The Revenue has grown by 11.18% in the past year. This is quite good.
The Revenue has been growing by 75.59% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-328.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)11.18%
Revenue growth 3Y42.34%
Revenue growth 5Y75.59%
Sales Q2Q%13.67%
3.2 Future
The Earnings Per Share is expected to grow by 74.44% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 15.53% on average over the next years. This is quite good.
EPS Next Y-12.22%
EPS Next 2Y104.72%
EPS Next 3Y96.71%
EPS Next 5Y74.44%
Revenue Next Year13.75%
Revenue Next 2Y21.31%
Revenue Next 3Y17.79%
Revenue Next 5Y15.53%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
HITI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 31.73, the valuation of HITI can be described as expensive.
Based on the Price/Forward Earnings ratio, HITI is valued a bit cheaper than the industry average as 74.19% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.52. HITI is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 31.73 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, HITI is valued a bit cheaper than 70.97% of the companies in the same industry.
70.97% of the companies in the same industry are more expensive than HITI, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.39 | ||
| EV/EBITDA | 10.78 |
4.3 Compensation for Growth
HITI's earnings are expected to grow with 96.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y104.72%
EPS Next 3Y96.71%
5. Dividend
5.1 Amount
No dividends for HITI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX-V:HITI (10/31/2025, 7:00:00 PM)
4.38
+0.09 (+2.1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners6.97%
Inst Owner ChangeN/A
Ins Owners8.32%
Ins Owner ChangeN/A
Market Cap382.07M
Revenue(TTM)568.25M
Net Income(TTM)-9797000
Analysts80
Price Target7.33 (67.35%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)194.66%
Min EPS beat(2)-8%
Max EPS beat(2)397.33%
EPS beat(4)1
Avg EPS beat(4)15.55%
Min EPS beat(4)-315.76%
Max EPS beat(4)397.33%
EPS beat(8)5
Avg EPS beat(8)75.15%
EPS beat(12)9
Avg EPS beat(12)61.94%
EPS beat(16)12
Avg EPS beat(16)45.88%
Revenue beat(2)1
Avg Revenue beat(2)-0.2%
Min Revenue beat(2)-1.49%
Max Revenue beat(2)1.09%
Revenue beat(4)3
Avg Revenue beat(4)0.59%
Min Revenue beat(4)-1.49%
Max Revenue beat(4)1.6%
Revenue beat(8)5
Avg Revenue beat(8)0.02%
Revenue beat(12)9
Avg Revenue beat(12)1.49%
Revenue beat(16)13
Avg Revenue beat(16)7.4%
PT rev (1m)-7.26%
PT rev (3m)2.68%
EPS NQ rev (1m)-100%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-27.27%
Revenue NQ rev (1m)4.57%
Revenue NQ rev (3m)6.53%
Revenue NY rev (1m)1.7%
Revenue NY rev (3m)1.57%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 31.73 | ||
| P/S | 0.67 | ||
| P/FCF | 19.39 | ||
| P/OCF | 13.07 | ||
| P/B | 2.7 | ||
| P/tB | 7.36 | ||
| EV/EBITDA | 10.78 |
EPS(TTM)-0.13
EYN/A
EPS(NY)0.14
Fwd EY3.15%
FCF(TTM)0.23
FCFY5.16%
OCF(TTM)0.34
OCFY7.65%
SpS6.51
BVpS1.62
TBVpS0.6
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.76% | ||
| ROE | -6.93% | ||
| ROCE | 6.4% | ||
| ROIC | 4.61% | ||
| ROICexc | 6.71% | ||
| ROICexgc | 18.48% | ||
| OM | 2.3% | ||
| PM (TTM) | N/A | ||
| GM | 25.83% | ||
| FCFM | 3.47% |
ROA(3y)-14.91%
ROA(5y)-13.84%
ROE(3y)-26.27%
ROE(5y)-34.31%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.25%
GM growth 5Y-5.48%
F-Score5
Asset Turnover2.18
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.43 | ||
| Debt/FCF | 4.08 | ||
| Debt/EBITDA | 1.67 | ||
| Cap/Depr | 41.17% | ||
| Cap/Sales | 1.68% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 80.65% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.85 | ||
| Quick Ratio | 1.29 | ||
| Altman-Z | 3.33 |
F-Score5
WACC7.78%
ROIC/WACC0.59
Cap/Depr(3y)28.99%
Cap/Depr(5y)34.63%
Cap/Sales(3y)1.88%
Cap/Sales(5y)2.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-328.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y-12.22%
EPS Next 2Y104.72%
EPS Next 3Y96.71%
EPS Next 5Y74.44%
Revenue 1Y (TTM)11.18%
Revenue growth 3Y42.34%
Revenue growth 5Y75.59%
Sales Q2Q%13.67%
Revenue Next Year13.75%
Revenue Next 2Y21.31%
Revenue Next 3Y17.79%
Revenue Next 5Y15.53%
EBIT growth 1Y2.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year418.19%
EBIT Next 3Y133.23%
EBIT Next 5Y81.08%
FCF growth 1Y38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.53%
OCF growth 3YN/A
OCF growth 5YN/A
HIGH TIDE INC / HITI.CA FAQ
What is the fundamental rating for HITI stock?
ChartMill assigns a fundamental rating of 4 / 10 to HITI.CA.
What is the valuation status of HIGH TIDE INC (HITI.CA) stock?
ChartMill assigns a valuation rating of 3 / 10 to HIGH TIDE INC (HITI.CA). This can be considered as Overvalued.
Can you provide the profitability details for HIGH TIDE INC?
HIGH TIDE INC (HITI.CA) has a profitability rating of 2 / 10.
What is the financial health of HIGH TIDE INC (HITI.CA) stock?
The financial health rating of HIGH TIDE INC (HITI.CA) is 5 / 10.
Can you provide the expected EPS growth for HITI stock?
The Earnings per Share (EPS) of HIGH TIDE INC (HITI.CA) is expected to decline by -12.22% in the next year.